(Updated - June 22, 2026 6:35 AM EDT)

Leerink initiates coverage on Altimmune (NASDAQ: ALT) with a Outperform rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE